Genentech sues Biogen as new wave of biosimilars disputes grows
Case concerns 20 asserted patents but this figure may be whittled down during litigation process
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.